The Global Adaptogen Wave and India's Ashwagandha Dominance
Ashwagandha (Withania somnifera) has transitioned from a traditional Ayurvedic herb to a globally traded functional ingredient, with India supplying over 80% of the world's raw ashwagandha root. The global adaptogen supplement market is projected to exceed $16 billion by 2028, and ashwagandha remains the single most commercially demanded adaptogen. In 2025-26, Indian ashwagandha exports crossed the $210 million mark, driven by robust demand from nutraceutical manufacturers in North America and the EU. Rajasthan and Madhya Pradesh remain the primary cultivation zones, with Nagori ashwagandha fetching a 15–20% premium for its higher withanolide content.
Quality Grades and Withanolide Standardization
International buyers increasingly demand withanolide-standardized ashwagandha root, with minimum 2.5% withanolide content becoming the industry benchmark. The premium KSM-66 full-spectrum extract requires roots with withanolide levels of 5% or higher, commanding FOB prices of $12–18/kg compared to $4–6/kg for conventional dried root. Organic certification adds another 20–30% price premium and is now considered a baseline requirement by major US and European contract manufacturers. Heavy metal testing, aflatoxin limits below 4 ppb, and pesticide residue panels compliant with EU MRLs are non-negotiable quality gates.
Request a full withanolide profile (HPLC method) along with heavy metal and pesticide residue certificates for every shipment. EU importers should verify that the supplier's organic certification covers the entire chain from farm to port.
EU Novel Food Status and Regulatory Landscape in 2026
The EU's evolving Novel Food Regulation framework has been a key catalyst for ashwagandha trade in 2026, with several authorized health claim dossiers now clearing the EFSA pipeline. Germany imported over 1,200 MT of ashwagandha root and extract in 2025, making it the largest EU market. The US FDA's GRAS status for ashwagandha root extract has been reaffirmed. India's APEDA and Spices Board have launched dedicated ashwagandha export promotion programs. Japan and South Korea are emerging as high-growth markets, with combined imports expected to reach $35 million by end of 2026.